.
15 junio 2020
Jazz Pharmaceuticals Announces U.S. FDA Accelerated Approval of Zepzelca™ (lurbinectedin) for the Treatment of Metastatic Small Cell Lung Cancer .
Entrada más reciente
Entrada antigua
Inicio